[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369015-105":59,"doc-detail-369015-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","riboflavin-plga-nanoparticles-enhance-the-effectiveness-of-the-pyruvate-carboxylase-inhibitor-zy-444-in-targeting-lipogenesis-in-colon-and-breast-cancer","Riboflavin-PLGA nanoparticles enhance the effectiveness of the pyruvate carboxylase inhibitor ZY-444 in targeting lipogenesis in colon and breast cancer","","Targeting cancer metabolism serves as a promising strategy for cancer therapy, with pyruvate carboxylase (PC) functioning as an anaplerotic enzyme that replenishes TCA intermediates. PC is overexpressed in aggressive breast and colon cancers, supporting growth, survival, and metastasis. This study extends ZY-444, a PC inhibitor previously reported in breast cancer, to highly aggressive colon cancer models and strengthens its activity using riboflavin-coated PLGA nanodelivery. Results show strong inhibition of clonogenic growth, reduced triglyceride and cholesterol, and amplified suppression of migration, invasion, and lipogenic enzyme expression, supporting targeted de novo lipogenesis blockade in colon and breast cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/riboflavin-plga-nanoparticles-enhance-the-effectiveness-of-the-pyruvate-carboxylase-inhibitor-zy-444-in-targeting-lipogenesis-in-colon-and-breast-cancer/369015/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/riboflavin-plga-nanoparticles-enhance-the-effectiveness-of-the-pyruvate-carboxylase-inhibitor-zy-444-in-targeting-lipogenesis-in-colon-and-breast-cancer/369015.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does pyruvate carboxylase (PC) play in cancer metabolism?","Question",{"text":112,"@type":113},"PC is an anaplerotic enzyme that replenishes TCA cycle intermediates by converting pyruvate to oxaloacetate, sustaining biosynthetic pathways that support tumor progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does ZY-444 relate to cancer treatment?",{"text":117,"@type":113},"ZY-444 is described as a pyruvate carboxylase inhibitor with reported anti-cancer activity in breast cancer, and this work extends its evaluation to aggressive colon cancer models.",{"name":119,"@type":110,"acceptedAnswer":120},"Why encapsulate ZY-444 in riboflavin-coated PLGA nanoparticles?",{"text":121,"@type":113},"The study uses PLGA nanocarriers with riboflavin-functionalized chitosan to improve delivery and targeting, resulting in markedly enhanced potency versus the free compound, along with stronger effects on lipogenic enzymes and lipid metabolism.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369015,1792186274,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nRiboflavin-PLGA nanoparticles enhance the effectiveness of the pyruvate carboxylase inhibitor ZY-444 in targeting lipogenesis in colon and breast cancer  \nSiraprapa Siritutsoontorn1, Preeyanuch Manohong1, Natthapat Sawektreeratana2, Chutima Kuhakarn2, Kanlaya Prapainop Katewongsa1􀀍 & Sarawut Jitrapakdee1􀀍  \nTargeting cancer metabolism has become a promising strategy for cancer treatment. Pyruvate carboxylase (PC) is an anaplerotic enzyme that replenishes tricarboxylic acid cycle intermediates. PC is overexpressed in several types of human cancers, especially in aggressive cancers, including breast and colon cancer, where it promotes growth, survival, and metastasis. Recently, N4-((5-(4-(benzyloxy) phenyl)-2-thiophenyl)methyl)-N2-isobutyl-2,4-pyrimidinediamine (ZY-444) has been reported to possess anti-cancer activity by inhibiting PC activity in breast cancer. In this study, we expanded the potential of ZY-444 to highly aggressive colon cancer, HT-29 and HCT116, and further enhanced its efficacy using nanodelivery systems. The results reveal that ZY-444 not only inhibits the clonogenic growth of these colon cancer cells but also downregulates the expression of several key lipogenic enzymes, accompanied by a marked reduction in triglyceride and cholesterol levels. To improve its efficacy, ZY-444 was encapsulated in poly(lactic-co-glycolic acid) (PLGA) nanoparticles with a surface coated with riboflavin (Rf)-functionalized chitosan (CSRf), a ligand known to target Rf transporters. The ZY-444-loaded PLGA nanoparticles exhibited a spherical morphology with an approximate size of 300 nm and a positive zeta potential, demonstrating their suitability for drug delivery applications. Compared with the free compound, ZY-444 encapsulated in nanoparticles demonstrated markedly enhanced efficacy being 11-, 14-, and 19-fold more potent in inhibiting the clonogenic growth of HT-29, HCT116, and MDA-MB-231 cells, respectively. In addition, the encapsulated form was over  \n10 times more effective at suppressing the migration and invasion of HCT116 and MDA-MB-231 cells. Encapsulated ZY-444 also more strongly inhibited the expression of lipogenic enzymes, further reinforcing its effect on lipid metabolism. Collectively, these findings underscore the potential of ZY- 444-loaded PLGA nanoparticles as a promising drug delivery system for suppressing colon and breast cancer through targeted inhibition ofthe de novo lipogenesis pathway.  \nKeywords ZY-444, Pyruvate carboxylase, Nanoparticles, PLGA, Breast cancer, Colon cancer  \nMetabolic reprogramming is a hallmark of cancer, enabling tumor cells to alter their metabolism to support rapid proliferation, metastasis, and drug resistance. These adaptations include enhanced aerobic glycolysis, the pentose phosphate pathway, glutaminolysis, and de novo lipogenesis to fulfill the anabolic demands required for sustained growth and survival1–4. Targeting key metabolic enzymes in these pathways has gained significant attention as a strategy to inhibit cancer growth and metastasis5,6. Pyruvate carboxylase (PC) is an important anaplerotic enzyme that replenishes tricarboxylic acid (TCA) cycle intermediates by carboxylating pyruvate to form oxaloacetate. This reaction sustains the biosynthetic pathways necessary for tumor progression. Previous studies have shown that PC is overexpressed in various types of cancers, with its expression correlating with clinicopathological parameters and poor prognosis in cancer patients7–10. Both genetic ablation of the PC  \n1Department of Biochemistry, Faculty of Science, Mahidol University, Rama 6 Rd, Bangkok 10400, Thailand.  \n2Department of Chemistry, Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Mahidol University, Rama 6 Rd, Bangkok 10400, Thailand. 􀀍 email: [kanlaya.pra@mahidol.ac.th](kanlaya.pra@mahidol.ac.th); [sarawut.jit@mahidol.ac.th](sarawut.jit@mahidol.a","cbCaicKJdY3joo6a","https://ap.wps.com/l/cbCaicKJdY3joo6a","pdf",4439093,18,"English","# Background\n## Cancer metabolism and pyruvate carboxylase (PC)\n## ZY-444 and its anti-cancer rationale\n# Nanoparticle delivery strategy\n## PLGA as a drug delivery platform\n## Riboflavin-coated nanodelivery concept","[{\"question\":\"What role does pyruvate carboxylase (PC) play in cancer metabolism?\",\"answer\":\"PC is an anaplerotic enzyme that replenishes TCA cycle intermediates by converting pyruvate to oxaloacetate, sustaining biosynthetic pathways that support tumor progression.\"},{\"question\":\"How does ZY-444 relate to cancer treatment?\",\"answer\":\"ZY-444 is described as a pyruvate carboxylase inhibitor with reported anti-cancer activity in breast cancer, and this work extends its evaluation to aggressive colon cancer models.\"},{\"question\":\"Why encapsulate ZY-444 in riboflavin-coated PLGA nanoparticles?\",\"answer\":\"The study uses PLGA nanocarriers with riboflavin-functionalized chitosan to improve delivery and targeting, resulting in markedly enhanced potency versus the free compound, along with stronger effects on lipogenic enzymes and lipid metabolism.\"}]","Riboflavin-PLGA nanoparticles enhance the effectiveness of the pyruvate carboxylase inhibitor ZY-444 in targeting lipogenesis in colon and breast cancer | PDF",1790180189,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/935832fea245824952a47ee9ad702647.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5fec0c286ff17336083cea7cb8bb064.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61130897df167049cadfb6b983836ad3.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65f3178e744b1ba268aefe6cef229667.webp",980,1287]